Analyst Estimates for Q1 2024Q4 2023Q1 2023Revenue4.81billion5.21 billion4.71billionDilutedEPS0.880.880.41Net Income391.52million403 million372millionKeyMetric:ResearchandDevelopmentSpendingThecompanysaidinitsfourth−quarterearningsreportthatitspentabout1.21 billion on research and development over fiscal 2023, an important part of which was investments in artificial intelligence (AI). In its Q4 presentation, GE HealthCare said its investments in technology including AI ...